Flora Peters

796 total citations
17 papers, 613 citations indexed

About

Flora Peters is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Flora Peters has authored 17 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Flora Peters's work include Cardiac electrophysiology and arrhythmias (11 papers), Cardiac Arrhythmias and Treatments (9 papers) and Cardiovascular Syncope and Autonomic Disorders (4 papers). Flora Peters is often cited by papers focused on Cardiac electrophysiology and arrhythmias (11 papers), Cardiac Arrhythmias and Treatments (9 papers) and Cardiovascular Syncope and Autonomic Disorders (4 papers). Flora Peters collaborates with scholars based in United States. Flora Peters's co-authors include Roger A. Winkle, Donald C. Harrison, Jay W. Mason, Peter J. Meffin, Robert E. Kates, Sandra R. Harapat, Magdi Sami, Patrice Jaillon, C. Tucker and Deborah Keefe and has published in prestigious journals such as Circulation, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

Flora Peters

16 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Flora Peters United States 13 440 104 99 89 78 17 613
PA Meredith United Kingdom 14 315 0.7× 158 1.5× 73 0.7× 121 1.4× 69 0.9× 33 646
Stots B. Reele United States 12 367 0.8× 76 0.7× 86 0.9× 145 1.6× 97 1.2× 22 701
Howard Warner United States 6 242 0.6× 53 0.5× 62 0.6× 99 1.1× 60 0.8× 10 521
E von Möllendorff United States 9 168 0.4× 72 0.7× 61 0.6× 59 0.7× 88 1.1× 12 430
W. Akpan United States 6 182 0.4× 83 0.8× 54 0.5× 44 0.5× 81 1.0× 9 384
T E Gaffney United States 14 203 0.5× 52 0.5× 103 1.0× 125 1.4× 70 0.9× 32 722
K. Reiff United States 9 187 0.4× 130 1.3× 50 0.5× 59 0.7× 98 1.3× 16 515
Yin‐Gail Yee United States 12 217 0.5× 96 0.9× 33 0.3× 77 0.9× 64 0.8× 16 510
Leonard Gonasun United States 15 137 0.3× 62 0.6× 110 1.1× 82 0.9× 99 1.3× 23 495
Ola Rönn Sweden 13 172 0.4× 83 0.8× 94 0.9× 60 0.7× 142 1.8× 25 545

Countries citing papers authored by Flora Peters

Since Specialization
Citations

This map shows the geographic impact of Flora Peters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flora Peters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flora Peters more than expected).

Fields of papers citing papers by Flora Peters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flora Peters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flora Peters. The network helps show where Flora Peters may publish in the future.

Co-authorship network of co-authors of Flora Peters

This figure shows the co-authorship network connecting the top 25 collaborators of Flora Peters. A scholar is included among the top collaborators of Flora Peters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flora Peters. Flora Peters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Winkle, Roger A., Flora Peters, Robert E. Kates, & Donald C. Harrison. (1983). Possible contribution of encainide metabolites to the long-term antiarrhythmic efficacy of encainide. The American Journal of Cardiology. 51(7). 1182–1188. 37 indexed citations
2.
Keefe, Deborah, Flora Peters, & Roger A. Winkle. (1982). Randomized double-blind placebo controlled crossover trial documenting oral lorcainide efficacy in suppression of symptomatic ventricular tachyarrhythmias. American Heart Journal. 103(4). 511–518. 29 indexed citations
3.
Winkle, Roger A., et al.. (1982). Acute hemodynamic effects of intravenous encainide in patients with heart disease. American Heart Journal. 104(2). 209–215. 21 indexed citations
4.
Rasmussen, Knut, Roger A. Winkle, D. Ross, et al.. (1982). Antiarrhythmic Efficacy of Amiodarone in Recurrent Ventricular Tachycardia Evaluated by Multiple Electrophysiological and Ambulatory ECG Recordings. Acta Medica Scandinavica. 212(6). 367–374. 10 indexed citations
5.
Jaillon, Patrice, David Rubenson, Flora Peters, Jay W. Mason, & Roger A. Winkle. (1981). Electrophysiologic effects of N-acetylprocainamide in human beings. The American Journal of Cardiology. 47(5). 1134–1140. 25 indexed citations
6.
Mason, Jay W. & Flora Peters. (1981). Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia.. Circulation. 63(3). 670–675. 72 indexed citations
7.
Winkle, Roger A., Patrice Jaillon, Robert E. Kates, & Flora Peters. (1981). Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide. The American Journal of Cardiology. 47(1). 123–130. 34 indexed citations
8.
Winkle, Roger A., Flora Peters, Robert E. Kates, C. Tucker, & Donald C. Harrison. (1981). Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmias.. Circulation. 64(2). 290–296. 63 indexed citations
10.
Schwartz, Janice B., Deborah Keefe, Flora Peters, Robert A. Kates, & Donald C. Harrison. (1981). Concentration dependent heart rate suppression with verapamil. The American Journal of Cardiology. 47. 406–406. 8 indexed citations
11.
Bjornsson, Thorir D., Peter J. Meffin, Flora Peters, & Terrence F. Blaschke. (1980). Saliva and plasma levels and plasma protein binding of clofibrinic acid in uremic patients. Clinical Pharmacology & Therapeutics. 27(2). 230–235. 5 indexed citations
12.
Sami, Magdi, Jay W. Mason, Flora Peters, & Donald C. Harrison. (1979). Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agent. The American Journal of Cardiology. 44(3). 526–532. 72 indexed citations
13.
Meffin, Peter J., et al.. (1979). Role of concentration-dependent plasma protein binding in disopyramide disposition. Journal of Pharmacokinetics and Biopharmaceutics. 7(1). 29–46. 113 indexed citations
14.
Winkle, Roger A., Julia Anderson, Flora Peters, et al.. (1978). The hemodynamic effects of intravenous tocainide in patients with heart disease.. Circulation. 57(4). 787–792. 43 indexed citations
15.
Meffin, Peter J., Roger A. Winkle, Flora Peters, et al.. (1978). Dose‐dependent acebutolol disposition after oral administration. Clinical Pharmacology & Therapeutics. 24(5). 542–547. 31 indexed citations
16.
Anderson, Jeffrey L., Jay W. Mason, Roger A. Winkle, et al.. (1978). Clinical electrophysiologic effects of tocainide. The American Journal of Cardiology. 41(2). 415–415.
17.
Meffin, Peter J., Roger A. Winkle, Flora Peters, & Donald C. Harrison. (1977). Acebutolol disposition after intravenous administration. Clinical Pharmacology & Therapeutics. 22(5part1). 557–567. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026